Cargando…

Functional and druggability analysis of the SARS-CoV-2 proteome

The infectious coronavirus disease (COVID-19) pandemic, caused by the coronavirus SARS-CoV-2, appeared in December 2019 in Wuhan, China, and has spread worldwide. As of today, more than 46 million people have been infected and over 1.2 million fatalities. With the purpose of contributing to the deve...

Descripción completa

Detalles Bibliográficos
Autores principales:	Cavasotto, Claudio N., Lamas, Maximiliano Sánchez, Maggini, Julián
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Elsevier B.V. 2021
Materias:	Full Length Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7604074/ https://www.ncbi.nlm.nih.gov/pubmed/33137330 http://dx.doi.org/10.1016/j.ejphar.2020.173705

Ejemplares similares

Genomics functional analysis and drug screening of SARS-CoV-2
por: Chen, Long, et al.
Publicado: (2020)

Cognitive function following SARS-CoV-2 infection in a population-representative Canadian sample
por: Hall, Peter A., et al.
Publicado: (2022)

Multipolymer microsphere delivery of SARS-CoV-2 antigens
por: Shahjin, Farah, et al.
Publicado: (2023)

Subjective neurological symptoms frequently occur in patients with SARS-CoV2 infection
por: Liguori, Claudio, et al.
Publicado: (2020)

Breakthrough SARS‐CoV‐2 infections in immune mediated disease patients undergoing B cell depleting therapy: A retrospective cohort analysis
por: Calabrese, Cassandra M, et al.
Publicado: (2022)

Mechanisms of instantaneous inactivation of SARS-CoV-2 by silicon nitride bioceramic
por: Pezzotti, G., et al.
Publicado: (2021)

Architecture and self‐assembly of the SARS‐CoV‐2 nucleocapsid protein
por: Ye, Qiaozhen, et al.
Publicado: (2020)

Unclear but present danger: An asymptomatic SARS-CoV-2 carrier
por: Yu, Xuejing, et al.
Publicado: (2020)

Nonstructural protein 7 and 8 complexes of SARS‐CoV‐2
por: Zhang, Changhui, et al.
Publicado: (2021)

DNA-scaffolded multivalent vaccine against SARS-CoV-2
por: Chen, Fangfang, et al.
Publicado: (2023)

Differential immune activation profile of SARS-CoV-2 and SARS-CoV infection in human lung and intestinal cells: Implications for treatment with IFN-β and IFN inducer
por: Shuai, Huiping, et al.
Publicado: (2020)

Patients with SARS-CoV-2 and HBV co-infection are at risk of greater liver injury
por: Lin, Yong, et al.
Publicado: (2020)

Identification of potent small molecule inhibitors of SARS-CoV-2 entry
por: Mediouni, Sonia, et al.
Publicado: (2022)

Severe Acute Respiratory Syndrome Coronavirus (SARS-CoV-1) and Middle East Respiratory Syndrome Coronavirus (MERS-CoV) infections in pregnancy – An overview
por: Babarinsa, Isaac A., et al.
Publicado: (2021)

Computational and theoretical exploration for clinical suitability of Remdesivir drug to SARS-CoV-2
por: Nayeem, Shaik Mahammad, et al.
Publicado: (2021)

In silico identification of strong binders of the SARS-CoV-2 receptor-binding domain
por: Behloul, Nouredine, et al.
Publicado: (2021)

Silencing SARS‐CoV Spike protein expression in cultured cells by RNA interference
por: Zhang, Yuanjiang, et al.
Publicado: (2004)

SARS-CoV2 neutralizing activity of ozone on porous and non-porous materials
por: Wolfgruber, Stella, et al.
Publicado: (2022)

Low rate of detection of SARS-CoV-2 RNA in deceased tissue donors
por: Greenwald, Melissa A., et al.
Publicado: (2022)

Amino acid variation analysis of surface spike glycoprotein at 614 in SARS-CoV-2 strains
por: Canhui Cao, et al.
Publicado: (2020)

Analysis of humoral and cellular immunity after SARS-CoV-2 vaccination in patients with multiple sclerosis treated with immunomodulatory drugs
por: Meca-Lallana, Virginia, et al.
Publicado: (2023)

Adsorption of SARS CoV-2 spike proteins on various functionalized surfaces correlates with the high transmissibility of Delta and Omicron variants
por: Dobrynin, Daniela, et al.
Publicado: (2022)

Changes in haemostasis and inflammatory markers after mRNA BNT162b2 and vector Ad26.CoV2.S SARS-CoV-2 vaccination
por: Ivanko, I., et al.
Publicado: (2023)

Effect of different human tissue processing techniques on SARS-CoV-2 inactivation-review
por: Paggiaro, André Oliveira, et al.
Publicado: (2020)

Corticosteroid therapy is associated with the delay of SARS-CoV-2 clearance in COVID-19 patients
por: Huang, Rui, et al.
Publicado: (2020)

Crystal structure of Nsp15 endoribonuclease NendoU from SARS‐CoV‐2
por: Kim, Youngchang, et al.
Publicado: (2020)

Longitudinal observation of antibody responses for 14 months after SARS-CoV-2 infection
por: Dehgani-Mobaraki, Puya, et al.
Publicado: (2021)

Insights into the conformation changes of SARS-CoV-2 spike receptor-binding domain on graphene
por: Du, Jianbin, et al.
Publicado: (2022)

A peptide-based assay discriminates individual antibody response to SARS-CoV-2
por: Polvere, Immacolata, et al.
Publicado: (2021)

Host and viral proteins involved in SARS‐CoV‐2 infection differentially bind heme
por: Hopp, Marie‐T., et al.
Publicado: (2022)

Wastewater-based epidemiological investigation of SARS-CoV-2 in Porto Alegre, Southern Brazil
por: Aschidamini Prandi, Bruno, et al.
Publicado: (2022)

Evolutionary trajectory of receptor binding specificity and promiscuity of the spike protein of SARS‐CoV‐2
por: Planchais, Cyril, et al.
Publicado: (2022)

Changes in buprenorphine visits in frontier and remote locations: Effects of the SARS-CoV-2 pandemic
por: McFadden, Lisa M.
Publicado: (2023)

In silico molecular docking analysis for repurposing therapeutics against multiple proteins from SARS-CoV-2
por: Deshpande, Rujuta R., et al.
Publicado: (2020)

Multiple sites on SARS‐CoV‐2 spike protein are susceptible to proteolysis by cathepsins B, K, L, S, and V
por: Bollavaram, Keval, et al.
Publicado: (2021)

SARS-CoV-2 proteins regulate inflammatory, thrombotic and diabetic responses in human arterial fibroblasts
por: Freda, Christopher Thor, et al.
Publicado: (2021)

Unraveling the mechanism of arbidol binding and inhibition of SARS-CoV-2: Insights from atomistic simulations
por: Padhi, Aditya K., et al.
Publicado: (2021)

Infection with SARS-CoV-2 primes immunological memory in human nasal-associated lymphoid tissue
por: Mahallawi, Waleed H., et al.
Publicado: (2021)

A cell-free high throughput assay for assessment of SARS-CoV-2 neutralizing antibodies
por: Mravinacova, Sara, et al.
Publicado: (2022)

Antibody Response to SARS-CoV-2 Vaccination in Patients following Allogeneic Hematopoietic Cell Transplantation
por: Huang, Alice, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_8mu7lphvadg5s00a5hgdji0mdq